Ophthalmology Doctors in Palm Springs, CA Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

Robert Barry Guss, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1180 N Indian Canyon, Suite 130, Palm Springs, CA 92262 Phone: 760-320-7051    Fax: 760-320-7683

Mr. William Carroll Murphy Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1775 E Palm Canyon Dr, # H309, Palm Springs, CA 92264 Phone: 760-832-2793

David Vaughn Leaming, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1180 N Indian Canyon Dr, Suite 130, Palm Springs, CA 92262 Phone: 760-320-7051    Fax: 760-320-7683

Dr. Wallace Franklin Goldban, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1180 N Indian Canyon Dr Ste W100, Palm Springs, CA 92262 Phone: 760-320-8497    Fax: 760-320-5444

Dr. Virginia A Klair, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 555 E Tachevah Dr, Suite 101e, Palm Springs, CA 92262 Phone: 760-327-1561    Fax: 760-327-4313

Dr. Sanjeev Grewal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1801 E Tahquitz Canyon Way, Suite 200, Palm Springs, CA 92262 Phone: 800-898-2020

News Archive

Researchers receive EPSRC grant to develop real-time diagnostic technique for dementia

A research team from Plymouth University, together with colleagues from Swansea University, has received funding of £1M from the Engineering and Physical Sciences Research Council to develop an innovative, real-time diagnostic technique for dementia using wonder-material graphene.

Taiyo Pacific Partners becomes third largest shareholder in CMIC

Taiyo Pacific Partners announced today that it has accumulated a position in excess of 5% in CMIC Co., Ltd. (2309) to become its third largest shareholder. Taiyo Pacific Partners is known for its cooperative investment style working with senior management to enhance shareholder value.

Arisaph Pharmaceuticals receives STTR grants to develop cancer drug candidates

Arisaph Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on discovery and development of novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a phase II Small Business Technology Transfer (STTR) grant and a supplemental phase I grant, both from the National Cancer Institute of the National Institutes of Health.

Maxim Integrated's MAX2082 octal ultrasound transceiver can save space, improve image quality

Ultrasound designers can now reduce form factor and improve image quality and reliability with the MAX2082 octal ultrasound transceiver from Maxim Integrated Products, Inc..

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.

Read more Medical News

› Verified 2 days ago